Select barriers to harm-reduction services for IDUs in EAstern Europe

Central European Journal of Public Health

Volumn 17, Issue 4, 2009, Pages 191-197

  Curth, Nadja Kehler ^a   Hansson, Liv Nanna ^a   Storm, Frederikke ^a   Lazarus, Jeffrey V ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Central asia; Eastern europe; Harm reduction; Health policy; Hepatitis; HIV

Indexed keywords

EID: 76649085189     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: 10.21101/cejph.a3562     Document Type: Article

References (38)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2001 AIDS epidemic update: Eastern Europe and Central Asia. Geneva: UNAIDS; 2001.
2. Reversing the tide: priorities for HIV/AIDS prevention in Central Asia. Washington, DC: World Bank; 2005.
3. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2007AIDS epidemic update: Eastern Europe and Central Asia. Geneva: UNAIDS; 2007.
4. Joint United Nations Programme on HIV/AIDS; World Health Organization (WHO). Progress on implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia. Copenhagen: WHO Regional Office for Europe; 2008.
5. Knerr W, Merkinaite S, editors. Hepatitis C among injecting drug users in the new EU member states and neighboring countries: situation, guidelines and recommendations. Vilnius: Central and Eastern European Harm Reduction Network; 2007.
6. Michielsen P, Bottieau E. Therapy of chronic hepatitis C in the setting of HIV co-infection. Acta Gastroenterol BeIg. 2005 Jan-Mar;68(l):86-91.
7. Schwalbe N, Lazarus JV, Adeyi O. HIV/AIDS and tuberculosis control in post-soviet countries. In: McKee M, Coker R, Atun RA, editors. Communicable diseases in Europe. Buckingham: Open University Press; 2008.
8. Elovich R, Drucker E. On drug treatment and social control: Russian narcology's great leap backwards. Harm Reduct J. 2008 Jun 24;5:23.
9. Donoghoe MC, Lazarus JV, Matic S. HIV/AIDS in the transitional countries of Eastern Europe and Central Asia. Clin Med. 2005 SepOct;5(5):487-490
10. Lazarus JV, Shete PB, Eramova I, Merkinaite S, Matic S. HIV/hepatitis coinfection in eastern Europe, and new pan-European approaches to hepatitis prevention and management. Int J Drug Policy. 2007 Oct; 18(5):42632. (Pubitemid 47374502)
11. Donoghoe MC. Injecting drug use, harm reduction and HIV/AIDS. In: Matic S, Lazarus JV, Donoghoe MC, editors. HIV/AIDS in Europe: moving from death sentence to chronic disease management. Copenhagen: WHO Regional Office for Europe; 2006.
12. World Health Organization [homepage on the Internet]. Evidence for action technical paper: effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. 2004 [cited 2008 May 13]. Available from: www.who.int/hiv/pub/prev-care/en/ef-fectivenesssterileneedle.pdf
13. Gowing L, Farrell M, Bornemann R, Sullivan L,AH R. Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2008 Apr 16;2(2):CD004145.
14. World Health Organization [homepage on the Internet]. Evidence for action technical paper: effectiveness of drug dependence treatment in preventing HIV among injecting drug users. 2005 [cited 2008 May 17]. Available from: http://www.who.int/hiv/pub/idu/drugdependence-final pdf.
15. Deren S, Beardsley M, Coyle S, Singer M. HIV serostatus and risk behaviors in a multisite sample of drug users. J Psychoactive Drugs. 1998 Jul-Sep;30(3):239-245 (Pubitemid 28467629)
16. Des Jarlais DC, Friedman SR. Critical issues regarding AIDS among injecting drug users. Bull Narc. 1993;45(1):61-75.
17. Harm Reduction Coalition [homepage on the Internet]. Principles of harm reduction [cited 2008 Jan 26]. Available from: http://www.harmreduction. org/article.php?list=type&type=62.
18. Open Society Institute [homepage on the Internet]. Harm reduction: questions and answers [cited 2008 Jan 26]. Available from: http://www. soros.org/initiatives/health/focus/ihrd/articles-publications/publications/ qa-20041123/harm-qa-english.pdf.
19. Atun RA. How European health systems have reacted to the HIV/AIDS epidemic. In: Matic S, Lazarus JV, Donoghoe MC, editors. HIV/AIDS in Europe: moving from death sentence to chronic disease management. Copenhagen: WHO Regional Office for Europe; 2006.
20. European Commission [homepage on the Internet]. Dublin Declaration on Partnership to fight HIV/AIDS in Europe and Central Asia. 2004 [cited 2008 May 12]. Available from: http://ec.europa.eu/health/ph-threats/com/aids/docs/dublin- decl.pdf.
21. Grund J-P, Merkinaite S, editors. Young people & injecting drug use in selected countries of Central and Eastern Europe. Vilnius: Eurasian Harm Reduction Network; 2009.
22. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2007. Stockholm: European Centre for Disease Prevention and Control; 2008.
23. European Monitoring Centre for Drugs and Drug Addiction [homepage on the Internet]. Statistical bulletin 2008 [cited 2008 May 12]. Available from: http://www.emcdda.europa.eu/stats08.
24. Mossialos E, Dixon A, Figueras J, Kutzin J, editors. Funding health care: options for Europe. Buckingham: Open University Press; 2002.
25. McCoy CB, Metsch LR, Chitwood DD, Miles C. Drug use and barriers to use of health care services. Subst Use Misuse 2001 May-Jun;36(67):789-806. (Pubitemid 32660804)
26. Bobrova N, Rhodes T, Power R, Alcorn R, Neifeld E, Krasiukov N, et al. Barriers to accessing drug treatment in Russia: a qualitative study among injecting drug users in two cities. Drug Alcohol Depend. 2006 Apr;82 Suppl l:S57-63.
27. Mehta SH, Thomas DL, Sulkowski MS, Safaein M, Vlahov D, Strathdee SA. A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users. AIDS. 2005 Oct;19 Suppl 3:S179-89.
28. Copeland J. A qualitative study of barriers to formal treatment among women who self-managed change in addictive behaviours. J Subst Abuse Treat. 1997 Mar-Apr; 14(2): 183-190 (Pubitemid 27342713)
29. Booth RE, Kwiatkowski C, Iguchi MY, Pinto F, John D. Facilitating treatment entry among out-of-treatment injection drug users. Public Health Rep. 1998 Jun;113 Suppl 1:116-128
30. Cronquist A, Edwards V, Galea S, Latka M, Vlahov D. Health care utilization among young adult injection drug users in Harlem, New York. J Subst Abuse. 2001 ; 13( 1 -2): 17-27. (Pubitemid 38209958)
31. Wolfe D. Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union. Int J Drug Policy. 2007 Aug; 18(4):246-254 (Pubitemid 47135597)
32. Maher L, Coupland H, Musson R. Scaling up HIV treatment, care and support for injecting drug users in Vietnam. Int J Drug Policy. 2007 Aug;18(4):296-305. (Pubitemid 47135595)
33. Bruce RD, Dvoryak S, SyIIa L, Altice FL. HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine-programme description and policy implications. Int J Drug Policy. 2007 Aug; 18(4):326-328 (Pubitemid 47135596)
34. UNAIDS [homepage on the Internet]. The Paris Declaration. 1994 [cited 2008 May 12]. Available from: http://data.unaids.org/pub/ExternalDocu-ment/2007/ theparisdeclaration-en.pdf
35. World Hepatitis Alliance [homepage on the Internet]. World hepatitis day [cited 2008 Sep 23]. Available from: http://www.aminumber12.org/.
36. World Health Organization [homepage on the Internet]. Technical guide for countries to set targets for universal access to HI V prevention, treatment and care for injecting drug users (IDUs) [cited 2009 Apr 7]. Available from: http://www.who.int/hiv/pub/idu/targetsetting/en/index.html.
37. Blystad H, Wiessing L. Guidance on provider-initiated voluntary medical examination: testing and counselling for infectious diseases in injecting drug users. Pre-final unedited version 4.5. Lisbon: EMCDDA; 2009.
38. White CL. Beyond professional harm reduction: the empowerment of multiply-marginalized illicit drug users to engage in a politics of solidarity towards ending the war on illicit drug users. Drug Alcohol Rev. 2001;20(4):449-458